Advancements in rheumatoid arthritis therapy: a journey from conventional therapy to precision medicine via nanoparticles targeting immune cells
Nanoscale · 2024 · 16 (32) · 14975-14993
DOI: 10.1039/d4nr02182g ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale, 2024. Verfasst von Anwesha Laha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biological and Life Sciences, School of Arts & Sciences, Ahmedabad University, Central Campus, Navrangpura, Ahmedabad 380009, Gujarat, India. ashutos…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Nanoparticles, Precision Medicine. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 203 Literaturangaben.
Abstract (Originalsprache)
Advancements in RA therapy from conventional drugs to nanomedicines based on immune cell therapy, which increases the specificity of the treatment and decreases the off-site effects, are reported. Images are created with BioRender.com.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biological and Life Sciences, School of Arts & Sciences, Ahmedabad University, Central Campus, Navrangpura, Ahmedabad 380009, Gujarat, India. ashutosh.kumar@ahduni.edu.in.
- Indian Institute of Technology Gandhinagar, Palaj, Gandhinagar - 382055, Gujarat, India.
Zitieren
APA
Laha, A., Nasra, S., Bhatia, D., & Kumar, A. (2024). Advancements in rheumatoid arthritis therapy: a journey from conventional therapy to precision medicine via nanoparticles targeting immune cells. Nanoscale, 16(32), 14975-14993. https://doi.org/10.1039/d4nr02182g
Vancouver
Laha A, Nasra S, Bhatia D, Kumar A. Advancements in rheumatoid arthritis therapy: a journey from conventional therapy to precision medicine via nanoparticles targeting immune cells. Nanoscale. 2024;16(32):14975-14993. doi:10.1039/d4nr02182g
BibTeX
@article{Laha2024,
author = {Laha, Anwesha and Nasra, Simran and Bhatia, Dhiraj and Kumar, Ashutosh},
title = {Advancements in rheumatoid arthritis therapy: a journey from conventional therapy to precision medicine via nanoparticles targeting immune cells},
journal = {Nanoscale},
year = {2024},
volume = {16},
number = {32},
pages = {14975--14993},
doi = {10.1039/d4nr02182g}
}
EUVIMED